Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Internal ribosome entry sequences

The plasmid vector pTEV-DHFR was used in this study. Internal ribosome entry sequence originated from tobacco etch virus (TEV) was locatai at upstream of dihydrofolate reductase (DHFR) gene. [Pg.170]

In a special class of internal initiations, the ribosomes bind at a specific internal AUG codon to start translation. The internal AUG may be located as far as 800 bases from the 5 end as in picornaviruses with uncapped, (+)-sense genomic RNAs. According to the model of cap-independent translation or internal ribosome entry (55), the internal RBS or ribosome landing pad is a 5 UTR sequence that forms a stable stem-loop structure. Hepatitis B virus (HBV) and some retroviruses also use an internal AUG codon, rather than ribosomal frameshifting, to express their reverse transcriptase genes (56,57). [Pg.18]

During a secondary screen we validated 6 of the 17 hits for their capacity to selectively reduce luciferase expression translationally driven from the APP 5 UTR but maintain co-expression of GFP with an internally controlled viral Internal Ribosome Entry Site (Dicistronic construct) [7]. For this puipose SY5Y neuroblastoma cells were stably transfected with the dicistronic construct (pJRl). The FDA drugs, dimercaptopropanol, paroxetine, azithromycin, quinoline-gluconate, tamsulosin and atorvastatin each suppressed luciferase reporter mRNA translation via the 146 nt APP 5 UTR sequence [111]. The iron... [Pg.234]

Figure 5, Primary screen far drugs targeted to the APP S untranslated region. In a screen of a library of 1,200 FDA-pre-approved compounds phenserine(ACHEi) and the potent intracellular iron chelator, desferrioxamine, were the validated positive control drugs that suppressed APP mRNA translation through APP 5 UTR sequences. In this transfection based screen several lead APP-5 UTR directed drugs were identified to limit luciferase gene expression driven by the APP 5 UTR. As an internal selectivity control for this screen, downstream dicistronic GFP gene expression (at the translational level by a viral internal ribosome entry site (IRES)) was unresponsive to drug action. Several leads (i,e, dimercaptopropanol) were identified to be chelators as described. Figure 5, Primary screen far drugs targeted to the APP S untranslated region. In a screen of a library of 1,200 FDA-pre-approved compounds phenserine(ACHEi) and the potent intracellular iron chelator, desferrioxamine, were the validated positive control drugs that suppressed APP mRNA translation through APP 5 UTR sequences. In this transfection based screen several lead APP-5 UTR directed drugs were identified to limit luciferase gene expression driven by the APP 5 UTR. As an internal selectivity control for this screen, downstream dicistronic GFP gene expression (at the translational level by a viral internal ribosome entry site (IRES)) was unresponsive to drug action. Several leads (i,e, dimercaptopropanol) were identified to be chelators as described.

See other pages where Internal ribosome entry sequences is mentioned: [Pg.67]    [Pg.102]    [Pg.108]    [Pg.67]    [Pg.102]    [Pg.108]    [Pg.80]    [Pg.82]    [Pg.167]    [Pg.2]    [Pg.89]    [Pg.66]    [Pg.68]    [Pg.228]    [Pg.54]    [Pg.254]    [Pg.496]    [Pg.497]    [Pg.98]    [Pg.146]    [Pg.254]    [Pg.2194]    [Pg.1368]    [Pg.273]    [Pg.15]    [Pg.38]    [Pg.167]    [Pg.134]    [Pg.202]    [Pg.731]    [Pg.7]   


SEARCH



Internal ribosome entry sequences IRESs)

© 2024 chempedia.info